|
Proteintech
ip experiment Ip Experiment, supplied by Proteintech, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/result/ip experiment/product/Proteintech Average 93 stars, based on 1 article reviews
ip experiment - by Bioz Stars,
2026-05
93/100 stars
|
Buy from Supplier |
|
Cell Signaling Technology Inc
ip experiment Ip Experiment, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/result/ip experiment/product/Cell Signaling Technology Inc Average 99 stars, based on 1 article reviews
ip experiment - by Bioz Stars,
2026-05
99/100 stars
|
Buy from Supplier |
|
Epizyme Inc
dykddddk ip/co-ip kit for co-ip experiments Dykddddk Ip/Co Ip Kit For Co Ip Experiments, supplied by Epizyme Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/result/dykddddk ip/co-ip kit for co-ip experiments/product/Epizyme Inc Average 90 stars, based on 1 article reviews
dykddddk ip/co-ip kit for co-ip experiments - by Bioz Stars,
2026-05
90/100 stars
|
Buy from Supplier |
|
SAS institute
co-ip experiments Co Ip Experiments, supplied by SAS institute, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/result/co-ip experiments/product/SAS institute Average 90 stars, based on 1 article reviews
co-ip experiments - by Bioz Stars,
2026-05
90/100 stars
|
Buy from Supplier |
|
Cell Signaling Technology Inc
chromatin immunoprecipitation chip experiment ![]() Chromatin Immunoprecipitation Chip Experiment, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 97/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/result/chromatin immunoprecipitation chip experiment/product/Cell Signaling Technology Inc Average 97 stars, based on 1 article reviews
chromatin immunoprecipitation chip experiment - by Bioz Stars,
2026-05
97/100 stars
|
Buy from Supplier |
|
Cell Signaling Technology Inc
chromatin immunoprecipitation experiment ![]() Chromatin Immunoprecipitation Experiment, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/result/chromatin immunoprecipitation experiment/product/Cell Signaling Technology Inc Average 96 stars, based on 1 article reviews
chromatin immunoprecipitation experiment - by Bioz Stars,
2026-05
96/100 stars
|
Buy from Supplier |
|
BioCampus Cologne
mass spectrometry for silac-ip experiments ![]() Mass Spectrometry For Silac Ip Experiments, supplied by BioCampus Cologne, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/result/mass spectrometry for silac-ip experiments/product/BioCampus Cologne Average 90 stars, based on 1 article reviews
mass spectrometry for silac-ip experiments - by Bioz Stars,
2026-05
90/100 stars
|
Buy from Supplier |
Journal: Clinical and Translational Medicine
Article Title: Oestrogen suppresses the adipogenesis of fibro/adipogenic progenitors through reactivating the METTL3–ESR1‐mediated loop in post‐menopausal females
doi: 10.1002/ctm2.70206
Figure Lengend Snippet: Oestrogen receptor 1 (ESR1) suppressed adipogenic differentiation of fibro/adipogenic progenitors (FAPs) by inhibiting transcription of peroxisome proliferator‐activated receptor gamma (PPARγ). (A) Bubble chart of GO analysis of up‐regulated and down‐regulated genes in FAPs from Esr1 knockout (KO) mouse when compared with those from Esr1 f/f mouse. Key GO terms were highlighted with red frames. (B) KEGG analysis of up‐regulated genes in FAPs from Esr1 KO mouse compared to those from Esr1 f/f mice. Key KEGG terms were highlighted with a red frame. (C) The sequence logo of potential ESR1 binding sites on the PPARγ promoter was predicted using JASPAR. (D) Scheme of construction of wild type (WT) and mutant pGL3‐PPARγ promoter reporter plasmids. (E, F) Protein levels and quantitative assessment of ESR1 and GAPDH after transfection with ESR1 overexpression (ESR1 OE) and vector (Vector) plasmids ( n = 3 per condition). (G) Quantitative assessment of luciferase activity after transfection with WT and mutant (Mut) pGL3‐PPARγ promoter reporter plasmids in female FAPs transfected with ESR1 overexpression plasmid ( n = 3 per condition). (H) Chromatin immunoprecipitation (ChIP)‐qPCR analysis for ESR1 binding to the PPARγ promoter in female FAPs under incubation with IgG or anti‐ESR1 antibodies ( n = 3 per condition). Data were shown as mean ± standard deviation (SD), ns indicated no significant differences, * indicated p < .05, *** indicated p < .001, **** indicated p < .0001.
Article Snippet: The
Techniques: Knock-Out, Sequencing, Binding Assay, Mutagenesis, Transfection, Over Expression, Plasmid Preparation, Luciferase, Activity Assay, Chromatin Immunoprecipitation, ChIP-qPCR, Incubation, Standard Deviation
Journal: Clinical and Translational Medicine
Article Title: Oestrogen suppresses the adipogenesis of fibro/adipogenic progenitors through reactivating the METTL3–ESR1‐mediated loop in post‐menopausal females
doi: 10.1002/ctm2.70206
Figure Lengend Snippet: Oestrogen receptor 1 (ESR1) enhanced expression of methyltransferase‐like 3 (METTL3) in turn by serving as a transcription factor in fibro/adipogenic progenitors (FAPs). (A, B) Dot blot and quantitative assessment of relative N6‐methyladenosine (m6A) methylation levels in FAPs from peri‐menopausal (Peri) and post‐menopausal patients (Post; n = 3 patients/group). (C, D) Dot blot and quantitative assessment of relative m6A methylation levels in FAPs from sham mouse (Control) and FAPs from ovariectomy (OVX) mouse ( n = 3 mice/group). (E) The sequence logo of potential ESR1 binding sites on the METTL3 promoter was predicted using JASPAR. (F) Scheme of wild type (WT) and mutant (Mut) pGL3‐METTL3 promoter reporter plasmids. (G, H) Protein levels and quantitative assessment of ESR1 and GAPDH in female FAPs transfected with vector (Vector) and ESR1 overexpression (ESR1 OE) plasmids ( n = 3 per condition). (I) Relative luciferase activity after transfection of WT and mutant (Mut) pGL3‐METTL3 promoter reporter plasmids in female FAPs transfected with ESR1 overexpression plasmid ( n = 3 per condition). (J) Chromatin immunoprecipitation (ChIP)‐qPCR for ESR1 binding to the METTL3 promoter in female FAPs under incubation with IgG or anti‐ESR1 antibodies ( n = 3 per condition). Data were shown as mean ± standard deviation (SD), ns indicated no significant differences, * indicated p < .05, *** indicated p < .001.
Article Snippet: The
Techniques: Expressing, Dot Blot, Methylation, Control, Sequencing, Binding Assay, Mutagenesis, Transfection, Plasmid Preparation, Over Expression, Luciferase, Activity Assay, Chromatin Immunoprecipitation, ChIP-qPCR, Incubation, Standard Deviation
Journal: Clinical and Translational Medicine
Article Title: Oestrogen suppresses the adipogenesis of fibro/adipogenic progenitors through reactivating the METTL3–ESR1‐mediated loop in post‐menopausal females
doi: 10.1002/ctm2.70206
Figure Lengend Snippet: E2 reactivated methyltransferase‐like 3 (METTL3)–oestrogen receptor 1 (ESR1)‐mediated loop in female post‐menopausal fibro/adipogenic progenitors (FAPs). (A) Chromatin immunoprecipitation (ChIP)‐qPCR for ESR1 binding to the peroxisome proliferator‐activated receptor gamma (PPARγ) promoter in female FAPs incubated with IgG or anti‐ESR1 antibodies following 3‐day treatments with either DMSO (Control) or oestrogen (E2) ( n = 3 per condition). (B) ChIP‐qPCR for ESR1 binding to the METTL3 promoter in female FAPs incubated with IgG or anti‐ESR1 antibodies following 3‐day treatments with either DMSO (Control) or oestrogen (E2) ( n = 3 per condition). (C, D) The protein levels of ESR1 and METTL3 in female post‐menopausal FAPs treated with DMSO (Control) or oestrogen (E2) ( n = 3 per condition). (E, F) Oil Red O staining and quantitative assessment of female post‐menopausal FAPs treated with DMSO (Control) or oestrogen (E2) following 10 days of adipogenic differentiation ( n = 5 per condition). Red indicated Oil Red O, blue indicated DAPI and the merged images were shown. Scale bar, 50 µm. (g) The mRNA expression of adipogenic and lipogenic genes in female post‐menopausal FAPs treated with DMSO (Control) or oestrogen (E2) following 10 days of adipogenic differentiation ( n = 3 per condition). Data were shown as mean ± standard deviation (SD), * indicated p < .05, ** indicated p < .01, *** indicated p < .001, **** indicated p < .0001.
Article Snippet: The
Techniques: Chromatin Immunoprecipitation, ChIP-qPCR, Binding Assay, Incubation, Control, Staining, Expressing, Standard Deviation